Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
On Target Laboratories, LLC
PMV Pharmaceuticals, Inc
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Whitehawk Therapeutics, Inc.
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
Sichuan Enray Pharmaceutical Sciences Company
A2 Biotherapeutics Inc.
Tizona Therapeutics, Inc
Essen Biotech
National Institutes of Health Clinical Center (CC)
Clasp Therapeutics, Inc.
University of Colorado, Denver
National Cancer Institute (NCI)
SystImmune Inc.
Pheon Therapeutics
Daiichi Sankyo
University of Nebraska
EXoPERT
Adela, Inc
Second Life Therapeutics
Eli Lilly and Company
Seagen Inc.
Medical College of Wisconsin
Varian, a Siemens Healthineers Company
Novartis
Dysplasia Diagnostics Limited
Elephas
Mayo Clinic
Varian, a Siemens Healthineers Company
Seagen Inc.
City of Hope Medical Center
University Health Network, Toronto
Hospices Civils de Lyon
Tempus AI
Chongqing Precision Biotech Co., Ltd
LigaChem Biosciences, Inc.
Washington University School of Medicine
Travera Inc